Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 203

1.
2.

Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000.

Ganguly R, Kotzan JA, Miller LS, Kennedy K, Martin BC.

J Clin Psychiatry. 2004 Oct;65(10):1377-88.

PMID:
15491242
4.

Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.

Morrato EH, Dodd S, Oderda G, Haxby DG, Allen R, Valuck RJ.

Clin Ther. 2007 Jan;29(1):183-95.

PMID:
17379060
5.

Patients with schizophrenia at risk for excessive antipsychotic dosing.

Walkup JT, McAlpine DD, Olfson M, Labay LE, Boyer C, Hansell S.

J Clin Psychiatry. 2000 May;61(5):344-8.

PMID:
10847308
6.

Clinical and social determinants of antipsychotic polypharmacy for Chinese patients with schizophrenia.

Xiang YT, Weng YZ, Leung CM, Tang WK, Ungvari GS.

Pharmacopsychiatry. 2007 Mar;40(2):47-52.

PMID:
17447172
7.

Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change.

Chong MY, Tan CH, Fujii S, Yang SY, Ungvari GS, Si T, Chung EK, Sim K, Tsang HY, Shinfuku N.

Psychiatry Clin Neurosci. 2004 Feb;58(1):61-7.

8.

Associations between adherence to guidelines for antipsychotic dose and health status, side effects, and patient care experiences.

Dickey B, Normand SL, Eisen S, Hermann R, Cleary P, Cortés D, Ware N.

Med Care. 2006 Sep;44(9):827-34.

PMID:
16932134
9.

Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective study.

Barbui C, Biancosino B, Esposito E, Marmai L, Donà S, Grassi L.

Int Clin Psychopharmacol. 2007 Jul;22(4):221-5.

PMID:
17519645
10.

Antipsychotic polypharmacy in outpatients at Birch Hill Hospital: incidence and adherence to guidelines.

Ranceva N, Ashraf W, Odelola D.

J Clin Pharmacol. 2010 Jun;50(6):699-704. doi: 10.1177/0091270009350625. Epub 2010 Jan 7.

PMID:
20056801
11.

Prescription profiles for pharmacological treatment of Japanese inpatients with schizophrenia: comparison between 2007 and 2009.

Yoshio T, Inada T, Uno J, Miwa T, Kitagawa K, Miyahara Y, Umeda K, Kato T, Inagaki A, Nabeshima T.

Hum Psychopharmacol. 2012 Jan;27(1):70-5. doi: 10.1002/hup.1272. Epub 2012 Jan 16.

PMID:
22249957
12.

Exploring regional variation in antipsychotic coprescribing practice: a Danish questionnaire survey.

Baandrup L, Allerup P, Nordentoft M, Lublin H, Glenthoj BY.

J Clin Psychiatry. 2010 Nov;71(11):1457-64. doi: 10.4088/JCP.09m05270yel. Epub 2010 Oct 19.

PMID:
21034689
13.

Psychiatrists' attitudes to maintenance medication for patients with schizophrenia.

Patel MX, Nikolaou V, David AS.

Psychol Med. 2003 Jan;33(1):83-9.

PMID:
12537039
14.

Clinical and social correlates with the use of depot antipsychotic drugs in outpatients with schizophrenia in China.

Xiang YT, Weng YZ, Leung CM, Tang WK, Ungvari GS.

Int J Clin Pharmacol Ther. 2008 May;46(5):245-51.

PMID:
18538110
15.

Antipsychotic polypharmacy in inpatients with schizophrenia in Asia (2001-2009).

Xiang YT, Wang CY, Si TM, Lee EH, He YL, Ungvari GS, Chiu HF, Yang SY, Chong MY, Tan CH, Kua EH, Fujii S, Sim K, Yong KH, Trivedi JK, Chung EK, Udomratn P, Chee KY, Sartorius N, Shinfuku N.

Pharmacopsychiatry. 2012 Jan;45(1):7-12. doi: 10.1055/s-0031-1286345. Epub 2011 Oct 11.

PMID:
21989602
16.

Antipsychotic polypharmacy and high-dose prescription in schizophrenia: a 5-year comparison.

Roh D, Chang JG, Kim CH, Cho HS, An SK, Jung YC.

Aust N Z J Psychiatry. 2014 Jan;48(1):52-60. doi: 10.1177/0004867413488221. Epub 2013 May 13.

PMID:
23671214
17.

Clinicians' reasons for deviations from recommended dosing practices for antipsychotic medications.

Sernyak MJ, Rosenheck R.

Adm Policy Ment Health. 2007 Nov;34(6):540-7.

PMID:
17957463
18.

The DEBIT trial: an intervention to reduce antipsychotic polypharmacy prescribing in adult psychiatry wards - a cluster randomized controlled trial.

Thompson A, Sullivan SA, Barley M, Strange SO, Moore L, Rogers P, Sipos A, Harrison G.

Psychol Med. 2008 May;38(5):705-15. Epub 2007 Sep 10.

PMID:
17825122
19.

Evaluation of a schizophrenia medication algorithm in a state hospital.

Chuang WC, Crismon ML.

Am J Health Syst Pharm. 2003 Jul 15;60(14):1459-67.

PMID:
12892030
20.

Antipsychotic polypharmacy at the University Psychiatric Hospital in Serbia.

Divac N, Jasović-Gasić M, Samardzić R, Lacković M, Prostran M.

Pharmacoepidemiol Drug Saf. 2007 Nov;16(11):1250-1.

PMID:
17960865

Supplemental Content

Support Center